Authors


James Hendrix, PhD

Latest:

James Hendrix, PhD: Progress and Challenges in the Alzheimer Space

Hendrix spoke to the challenges he and colleagues come across, as well as his hope for the promising future.


Jill Jarecki, PhD

Latest:

Spinal Muscular Atrophy and COVID-19: Guidance and Resources for Providers

Advocacy organization Cure SMA provides guidance for health care providers caring for patients with SMA during the ongoing COVID-19 pandemic.


Rohit Dhall, MD, MSPH

Latest:

Noninvasive Neuromodulation for Essential Tremor: An Important Tool for Maintaining Independence at Home

Noninvasive neuromodulation with TAPS is a safe and effective tool that offers particular utility in the age of COVID-19 when other treatment options may be less accessible.


Staff Writer

Latest:

Gene Therapy Shows Robust Activity for Duchenne Muscular Dystrophy

A novel gene therapy has demonstrated impressive early results in a small sample of 3 children with Duchenne muscular dystrophy.


Jeffrey Ratliff, MD

Latest:

An Emerging Framework for Parkinson Disease Therapeutics

The diagnosis of Parkinson disease may seem straightforward at first, requiring neurologists to rely on their eyes and hands, but the treatment process can present challenges for both physicians and patients.


Andrew Russman, DO

Latest:

Understanding the Evolving Care of Rehabilitation and Stroke Recovery

Explore innovative neurorehabilitation strategies for stroke recovery, emphasizing personalized approaches and advanced technologies to enhance patient outcomes.


Peter Nakaji, MD

Latest:

Peter Nakaji, MD: The State of Science for Epilepsy Surgery

The chair of the Department of Neurosurgery at Banner-University Medical Center discusses the current state of the science being done in the realm of epilepsy surgery.



Katrina Celis, MD

Latest:

Katrina Celis, MD: Genetics and Their Role in Alzheimer Research, Clinical Care

The postdoctoral fellow at the University of Miami Miller School of Medicine detailed the role that increased APOE ε4 expression can have on future research and clinical care.



Naeem Khan, MD

Latest:

Naeem Khan, MD: Ticagrelor Shines in Phase 3 THALES Trial

The vice president of AstraZeneca’s Cardiovascular and Metabolic Diseases Portfolio detailed the results from the phase 3 THALES trial, and where ticagrelor stands among other FDA approved stroke treatments.


Marwan Sabbagh, MD

Latest:

The Future Outlook for Alzheimer’s Disease

Sharon Cohen, MD, and Marwan Sabbagh, MD, share their final thoughts on Alzheimer's disease and offer advice on strategies to reduce the risk of developing AD and slow the progression of the disease for those already affected.


Kathleen Hawker, MD

Latest:

Kathleen Hawker, MD: Clinical Findings for Satralizumab in Treating NMOSD

The group medical director of neuroscience at Genentech spoke to the findings recently presented at the 6th Annual Meeting of the European Academy of Neurology.


Stuart H. Isaacson, MD, FAAN

Latest:

Clinical Nurse Educators, Dosing Titrations to Manage Parkinson Disease

Panelists discuss how clinical nurse educators serve as vital partners in continuous subcutaneous apomorphine infusion management, providing patient education, troubleshooting technical issues, and collaborating with physicians on dosing titrations to optimize Parkinson disease symptom control.



Dawn Buse, PhD

Latest:

Dawn Buse, PhD: Inappropriate Prescriptions in Acute, Preventive Migraine Treatment

The clinical professor of neurology at Albert Einstein College of Medicine spoke to the findings of the OVERCOME study, and how recent literature has suggested that improper prescriptions and medication use in migraine have been ongoing in spite of the current recommendations.


Amy Sullivan, PsyD

Latest:

Amy Sullivan, PsyD: Personalized Approach to Fatigue in Multiple Sclerosis

The Director of Behavioral Medicine at the Mellen Center for MS Treatment and Research at the Cleveland Clinic spoke about how she approaches fatigue in MS from a behavioral standpoint.


Jeff Waugh, MD, PhD

Latest:

Jeff Waugh, MD, PhD: Viewing Striatal Injury More Granularly

Despite some mistrusting the abilities of imaging to aid in therapeutic development, a new MRI method could better inform the anatomical understanding of the striatum.


Patricia K. Coyle, MD

Latest:

The Role of High-Efficacy Therapies in Multiple Sclerosis Treatment: Patricia K. Coyle, MD

At the 2025 ACTRIMS Forum, the director of the MS Comprehensive Care Center at Stony Brook Medicine discussed the evolution of high-efficacy treatments for MS. [WATCH TIME: 4 minutes]



Dominic Pelle, MD

Latest:

Dominic Pelle, MD: Improving Patient-Reported Outcomes in Spine Surgery

The spine surgeon in the Center for Spine Health at Cleveland Clinic spoke to the importance of improving patient-reported outcomes and ensuring consistent communication with patients undergoing spine surgery.



James Leverenz, MD

Latest:

Promising Diagnostic Approaches Emerging for Brain Pathologies: James Leverenz, MD

The director of the Cleveland Lou Ruvo Center for Brain Health at Cleveland Clinic discussed new diagnostic techniques that show promise for advancing the understanding of brain pathologies like Alzheimer and Lewy Body diseases. [WATCH TIME: 3 minutes]


Jerrold L. Vitek, MD, PhD

Latest:

Jerrold L. Vitek, MD, PhD: Multiple Independent Contact Current-Controlled DBS Technology

The professor and head of the department of neurology at the University of Minnesota discussed what multiple independent contact current-controlled devices offer physicians conducting deep brain stimulation.


Mia Minen, MD, MPH

Latest:

Mia Minen, MD, MPH: Behavioral Therapies for Posttraumatic Headache

Mia Minen, MD, MPH, sat down for an interview to discuss why behavioral therapies could be an effective and easily accessible treatment for posttraumatic headaches following events like concussions.


Eugenia Trushina, PhD

Latest:

Eugenia Trushina, PhD: Communication and Learning Through Collaboration

For the associate professor of neurology, learning, listening, and collaborating are the keys to improving the field of care.


Chia-Chun Chiang, MD

Latest:

Using AI to Assist in Identifying Cardiovascular Risk in Patients With Migraine

Chia-Chun Chiang, MD, associate professor of neurology at Mayo Clinic Rochester, discussed how AI-based ECG and imaging tools can aid in predicting stroke and cardiovascular outcomes in patients with migraine.


Ronald C. Petersen, MD, PhD

Latest:

The Potential of Blood Tests to Improve Screening and Monitoring in Alzheimer Disease Clinical Trials: Ronald C. Petersen, MD, PhD

The director of the Alzheimer’s Disease Research Center at Mayo Clinic detailed the current issues with access and affordability to critical biomarkers in the screening and monitoring of patients in Alzheimer disease trials. [WATCH TIME: 3 minutes]



David K. B. Li, MD, FRCPC

Latest:

The Importance of a Globally Aligned, Standardized MRI Protocol for MS

Leaders of the CMSC Working Group on MRI protocols and clinical guidelines express the need for a unified approach to diagnosing and monitoring multiple sclerosis.

© 2025 MJH Life Sciences

All rights reserved.